Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

400 ARTÍCULOS , VIENDO DEL 91 AL 105

Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes

Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang S, Jack CR Jr, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Radiology. 2011 Jun;259(3):844-51. doi: 10.1148/radiol.11101637. Epub 2011 Apr 5.

Declines in problem solving and anosognosia in amyotrophic lateral sclerosis: application of Guilford's structure of intellect theory

Flaherty-Craig CV, Brothers A, Yang C, Svoboda R, Simmons Z.

Cogn Behav Neurol. 2011 Mar;24(1):26-34. doi: 10.1097/WNN.0b013e3182138454.

Association between prescription of conventional or atypical antipsychotic drugs and mortality in older persons with Alzheimer's disease

Musicco M, Palmer K, Russo A, Caltagirone C, Adorni F, Pettenati C, Bisanti L.

Dement Geriatr Cogn Disord. 2011;31(3):218-24. doi: 10.1159/000326213. Epub 2011 Apr 6.

Screening for cognitive dysfunction in corticobasal syndrome: utility of Addenbrooke's cognitive examination

Mathew R, Bak TH, Hodges JR.

Dement Geriatr Cogn Disord. 2011;31(4):254-8. doi: 10.1159/000327169. Epub 2011 Apr 8.

Changes in nursing burden following memantine for agitation and aggression in long-term care residents with moderate to severe Alzheimer's disease: an open-label pilot study

Herrmann N, Cappell J, Eryavec GM, Lanctôt KL.

CNS Drugs. 2011 May;25(5):425-33. doi: 10.2165/11588160-000000000-00000.

Using cognitive decline in novel trial designs for primary prevention and early disease-modifying therapy trials of Alzheimer's disease

Darby D, Brodtmann A, Woodward M, Budge M, Maruff P.

Int Psychogeriatr. 2011 Nov;23(9):1376-85. doi: 10.1017/S1041610211000354. Epub 2011 Apr 11.

Neuropsychiatric symptoms in Lewy body diffuse disease: a case report

Salazar G, Cuello D, Fragoso M, Benlloc L.

Neurologia. 2011 Oct;26(8):499-502. doi: 10.1016/j.nrl.2011.01.020. Epub 2011 Apr 7.

Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links

Sokol DK, Maloney B, Long JM, Ray B, Lahiri DK.

Neurology. 2011 Apr 12;76(15):1344-52. doi: 10.1212/WNL.0b013e3182166dc7.

Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot study

Buschert VC, Friese U, Teipel SJ, Schneider P, Merensky W, Rujescu D, Möller HJ, Hampel H, Buerger K.

J Alzheimers Dis. 2011;25(4):679-94. doi: 10.3233/JAD-2011-100999.

Comparison of diffusion tensor image study in association fiber tracts among normal, amnestic mild cognitive impairment, and Alzheimer's patients

Zhang YZ, Chang C, Wei XE, Fu JL, Li WB.

Neurol India. 2011 Mar-Apr;59(2):168-73. doi: 10.4103/0028-3886.79129.

[Dementia with Lewy bodies (DLB) accompanied by symptoms of late catatonia: what to consider and how to treat]

Ueda S, Koyama K, Kocha H, Okubo Y.

Seishin Shinkeigaku Zasshi. 2011;113(2):144-56.

Women have farther to fall: gender differences between normal elderly and Alzheimer's disease in verbal memory engender better detection of Alzheimer's disease in women

Chapman RM, Mapstone M, Gardner MN, Sandoval TC, McCrary JW, Guillily MD, Reilly LA, DeGrush E.

J Int Neuropsychol Soc. 2011 Jul;17(4):654-62. doi: 10.1017/S1355617711000452.

[Alzheimer's disease and vascular risk factors]

Hanon O, Duron E.

Rev Med Interne. 2011 Jun;32 Suppl 1:S17-21. doi: 10.1016/j.revmed.2011.03.004. Epub 2011 Apr 13.

Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis

Elias-Sonnenschein LS, Viechtbauer W, Ramakers IH, Verhey FR, Visser PJ.

J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1149-56. doi: 10.1136/jnnp.2010.231555. Epub 2011 Apr 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias